Back to company

ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDEN: Financial statements 2023

CVR: 19040089

ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDEN (CVR 19040089) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 2,128,683 and a net result of DKK 1,366,095 compared with DKK -935,786 the year before. That is an increase of 4.6% compared with the year before. The profit margin was 64.2%. Equity amounted to DKK 14,376,545. The solvency ratio was 95.8%.

Revenue
2,128,683 kr.
Gross Profit
515,643 kr.
Profit/Loss
1,366,095 kr.
Equity
14,376,545 kr.
Total Assets
15,014,663 kr.
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20232.1 mio.516 t.1.4 mio.14.4 mio.0
20222 mio.247 t.-936 t.13.7 mio.0
20211.8 mio.495 t.1.6 mio.15.9 mio.-
20202 mio.586 t.951 t.15.5 mio.-
20191.7 mio.-87 t.1.9 mio.14.9 mio.0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDEN: The 2022 annual report is outJun 28, 2023

ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDEN has published its annual report for 2022. Revenue came to DKK 2,035,496, and the net result was DKK -935,786.

About ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDEN

ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDEN is a Danish company of the type Erhvervsdrivende fond based in København V, founded in 1999. The company is registered under the industry Andre udgiveraktiviteter, undtagen udgivelse af software. The management consists of Sören Erik Pischke. In 2024, the company reported revenue of DKK 2,351,812 and a net result of DKK 1,569,542 compared with DKK 1,366,095 the year before. Equity amounted to DKK 14,950,740.